Cytek Biosciences, Inc. Acquires Tonbo Biosciences? Cell Analysis Business
November 03, 2021 at 08:00 am EDT
Share
Cytek Biosciences, Inc. announced that it has acquired the cell analysis business of Tonbo Biosciences?, which includes an extensive portfolio of life science research reagents related to cell preparation, flow cytometry, molecular immunology/PCR and cell culture covering application areas across immunology, apoptosis, and immunoprofiling. The addition of the Tonbo Biosciences portfolio of reagents will enable Cytek to offer extended flow cytometry capabilities to meet customer needs in protein and cell analysis research. Tonbo?s reagents will complement Cytek?s cFluor? family of proprietary reagents, which represent the culmination of years of experience understanding full spectrum cytometry and how fluorophores react together in multicolor panels.
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.
CYTEK BIOSCIENCES, INC. 
